Watchlist

Watchlist
Acasti Pharma, Inc. (ACST)
Acasti Pharma, Inc. (ACST)
Midday Gainers / Losers
Gainers: CERC +45% . MARA +29% . MGCD +24% . SGRP +21% . NOG +20% . GROW +19% . OPHC +18% . UTSI +17% . CUDA +16% . QD +16% . More news on: Cerecor, Marathon Patent Group, Inc., MGC Diagnostics Corporation, Stocks on the move, Read more …
Week In Review: China Renaissance Sets $7 Billion Goal For New VC/PE Funds, Including Biotech/Healthcare
Deals and Financings China Renaissance, a Beijing investment bank and VC/PE investor, plans to expand its investment funds operations, climbing from $3 billion assets under management currently to $10 billion over the next three years. At the moment, the company runs two funds: Huaxing G…
Midday Gainers / Losers
Gainers: CLSN +47% . OTCPK:OMNT +33% . ACHV +26% . ATOM +25% . CADC +20% . EKSO +19% . XNET +18% . CMCM +18% . RELV +17% . CUB +15% . More news on: Celsion Corporation, Ominto, Inc., Achieve Life Sciences, Inc., Stocks on the move, Read more …
Premarket Losers as of 9:05 am
CYTK -34% on announcing negative results from VITALITY-ALS. More news on: Cytokinetics, Incorporated, Qudian, Inc., Acasti Pharma, Inc., Stocks on the move, Read more …
Midday Gainers / Losers
Gainers: ACST +136% . OPHC +60% . DCIX +27% . TSRI +26% . XNET +27% . EKSO +23% . CARV +25% . SRAX +19% . NTIC +18% . IMI +16% . More news on: Acasti Pharma, Inc., OptimumBank Holdings, Inc., Diana Containerships Inc., Stocks on the move, Read more … ...
Acasti Pharma advancing potential deal to commercialize CaPre in Asia; shares ahead 75%
Thinly traded nano cap Acasti Pharma ( ACST +74.8% ) is up on a whopping 317x surge in volume in response to its announcement that it has entered into a non-binding term sheet with a leading Chinese pharmaceutical company that it expects to lead to a formal license agreement for the comm…
Acasti Pharma reports Q2 results
Acasti Pharma (NASDAQ: ACST ): Q2 EPS of -$0.31 Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, ,
Acasti Pharma reports Q1 results
Acasti Pharma (NASDAQ: ACST ): Q1 EPS of -$0.19 Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, ,
Acasti Pharma reports Q4 results
Acasti Pharma (NASDAQ: ACST ): Q4 EPS of -$0.23 Cash and equivalents of $9.8M Press Release More news on: Acasti Pharma, Inc., Earnings news and commentary, Healthcare stocks news, ,
Interview: Neptune Wellness Solutions CEO Jim Hamilton
Seeking Alpha Contributor Travis Brown spoke with Neptune Wellness Solutions/Neptune Technologies & Bioressources Inc. (NASDAQ: [[NEPT]]) CEO Jim Hamilton in a telephone interview. The following contains a summary of the interview, sound bites via Soundcloud, and an update to the Au…
Midday Gainers / Losers
Gainers: MRNS +34% . GLBS +19% . BOXC +18% . ACST +14% . GNK +14% . GLBL +11% . DFBG +10% . PME +10% . TGH +10% . More news on: Marinus Pharmaceuticals, Globus Maritime Ltd., Brookfield Canada Office Properties, Stocks on the move, Read more …
Acasti Pharma, Inc. (ACST)